Journal profile

Journal of psychiatric practice

Publisher: Lippincott Williams & Wilkins
ISSN1527-4160 | 1538-1145 FormatPrint StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
2.45
Citation rate 1.00 148 total citations
h5-index 15 h5 depth signal
Cited share 45.0% 67 of 149
Total citations 148 Citation footprint
Metric signal 1.16 External metric anchor
Self-citation 7.4% 11 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

United States 497
Canada 29
Turkey 15
Italy 15
Switzerland 13

Citing Fields of Research

Psychiatry 556
Psychiatry & Psychology 171
Substance Abuse 62
Neurosciences 35
Brain Neurological Disorders 32

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 2,071 Articles tracked across the journal lifetime
Indexed publication set 149 67 cited publications
Last 12 months 68 11.3 publications/month
Open access share 2.9% 2 OA publications in the last year
Leading citing country United States 497 citing publications
Leading citing field Psychiatry 556 citing publications
Latest tracked publication 1 September 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v10n1, Jan. 2004-
PubMed
v10n1, Jan. 2004-
Index medicus
Active Coverage

Research Focus & Classification

Indexed Subjects

Psychiatry

Broad Categories

Psychiatry Psychiatry

MeSH Descriptors

Mental Disorders Psychotherapy

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

01
Chanel Zhan, Tyler Zahrli, Benjamin Hoover
Serotonin syndrome (SS) is a rare but potentially life-threatening condition resulting from increased serotoninergic activity in the central nervous system, either from exposure to a serotonin agonist or from withdrawal of a serotonin an...
03
DOI 10.1097/pra.0000000000000943

Therapy-Interfering Interfering Behavior

Open DOI
Lauren M. Borges, Sean M. Barnes, Ryan Holliday et al.
Therapy-interfering behavior (TIB), although commonly encountered in clinical practice, often goes unaddressed. But if behaviors preventing treatment engagement are not addressed, patients will struggle to achieve their treatment goals, ...
04
José Martínez-Raga, Begoña Soler-López, José Ángel Alcalá et al.
Background and Objectives: Duloxetine is a serotonin and norepinephrine reuptake inhibitor antidepressant drug. The goal of this project was to analyze the characteristics of patients with major depressive disorder (MDD) treated with dul...
08
Dragos-Paul Hagiu, Lina Hamdi, Edouard Ollier et al.
Objectives: To systematically evaluate the incidence and prevalence of drug-induced QT interval prolongation and torsades de pointes (TdP) among adults exposed to QT-prolonging medications. Design: Systematic review of observational and ...
09
Kyle D. Webster, Alyssa C. Smith, Katharine MacMillan et al.
Objective: Medical students are disproportionately affected by mental health conditions. It is therefore crucial to improve access to care for this population. To do this requires an understanding of where students seek treatment and wha...
10
Talia S. Nasr, Alyssa C. Smith, Hanna E. Degen
Lamotrigine toxicity may be associated with a variety of nonspecific clinical findings, and rarely with psychosis. Many previous studies have reported that the use of lamotrigine with other agents, such as valproic acid, or an overdose o...

Bibliographical & Catalog Notes

Title from cover.

Print issues ceased with 2015.

Also issued online.

Abstracts available online. Subscription required for full text.

v. 1, no. 1 (JAN 1993)20040802 Notice published Printed on acid-free paper